Abstract
The Hiperdia Program, implemented in Brazil, is a fundamental strategy in the control and management of hypertension and diabetes mellitus in primary health care. This integrative review aimed to evaluate the effectiveness of the program in improving treatment adherence, reducing complications, and promoting patients' quality of life. We selected 20 articles published between 2013 and 2023, in databases such as PubMed, Scielo, and Lilacs, using the descriptors "Hiperdia," "hypertension," "diabetes," "primary care," and "chronic disease management." The results demonstrate that Hiperdia is effective in identifying, registering and monitoring patients, promoting educational actions and ensuring access to essential medicines. Studies point to significant improvements in treatment adherence and in the reduction of hospitalizations due to cardiovascular and metabolic complications. However, challenges include gaps in infrastructure, discontinuity of funding, and difficulties in integrating health teams. It is proposed to expand technological support, training of professionals and telemonitoring strategies as tools to enhance the results of the program. It is concluded that Hiperdia is essential for the confrontation of chronic non-communicable diseases, but requires greater investment and strategic planning to consolidate its effectiveness in primary care.
DOI: https://doi.org/10.56238/sevened2024.039-015